No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:46554200-46564600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
2 |
chr17:46555000-46566000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
3 |
chr17:46559200-46566200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
4 |
chr17:46560800-46564600 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
5 |
chr17:46560800-46566000 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
6 |
chr17:46560800-46566400 |
Enhancers |
HMEC |
breast
|
7 |
chr17:46561200-46566000 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
8 |
chr17:46561200-46566200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
9 |
chr17:46561200-46566200 |
Weak transcription |
Primary T helper cells fromperipheralblood |
blood
|
10 |
chr17:46561400-46566600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
11 |
chr17:46561400-46569400 |
Weak transcription |
Primary T killer memory cells from peripheral blood |
blood
|
12 |
chr17:46561400-46569600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
13 |
chr17:46561800-46564800 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
14 |
chr17:46561800-46566000 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
15 |
chr17:46561800-46567400 |
Weak transcription |
Colon Smooth Muscle |
Colon
|
16 |
chr17:46562000-46564800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
17 |
chr17:46562000-46565000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
18 |
chr17:46562000-46567600 |
Weak transcription |
Rectal Smooth Muscle |
rectum
|
19 |
chr17:46562000-46569800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
20 |
chr17:46562200-46565000 |
Enhancers |
NH-A |
brain
|
21 |
chr17:46562400-46564800 |
Enhancers |
NHLF |
lung
|
22 |
chr17:46562400-46567800 |
Weak transcription |
GM12878-XiMat |
blood
|
23 |
chr17:46563200-46564600 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
24 |
chr17:46563200-46564800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
25 |
chr17:46563400-46564600 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
26 |
chr17:46563600-46569200 |
Enhancers |
K562 |
blood
|
27 |
chr17:46563800-46564600 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
28 |
chr17:46563800-46564600 |
Enhancers |
A549 |
lung
|
29 |
chr17:46563800-46564800 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
30 |
chr17:46563800-46564800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
31 |
chr17:46563800-46565000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
32 |
chr17:46563800-46565000 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
33 |
chr17:46563800-46565600 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
34 |
chr17:46564200-46564600 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
35 |
chr17:46564200-46564600 |
Flanking Active TSS |
HSMM |
muscle
|
36 |
chr17:46564200-46564800 |
Flanking Active TSS |
NHEK |
skin
|
37 |
chr17:46564200-46567600 |
Weak transcription |
Adipose Nuclei |
Adipose
|
38 |
chr17:46564400-46565000 |
Enhancers |
HSMMtube |
muscle
|
39 |
chr17:46564400-46565000 |
Enhancers |
NHDF-Ad |
bronchial
|
40 |
chr17:46564400-46565000 |
Enhancers |
Osteobl |
bone
|